MEaDvise
MEaDvise improves pre-diabetic and diabetic patients’ outcomes and reduces the cost for insurers and individuals through personalized risk identification, care coordination, and digital health intervention. MEaDvise Team: Abbas Shojaee
Read MoreMIDA Project
MIDA Project is developing a high throughput screen test for detection of MVID among patients with diarrhea. MIDA Project Team: Ludmilla Kvochina
Read MoreDeMay Bio
DeMay Bio is developing a biologic drug for Rheumatoid Arthritis that leverages a natural human protein to target a novel, but validated, disease mechanism directly in the joints. The new drug is an adjunct therapy, to be used alongside a patient’s immunosuppressant regimen, to achieve better disease control, and to reduce disabling joint pain, tissue…
Read MoreASTHMAXcel
The ASTHMAXcel mobile application is a patient-facing self- management tool with personalizable features (tailored algorithms, animated educational videos, adherence support messages, games, self-assessments, patient/provider dashboards). ASTHMAXcel Team: Sunit Jariwala
Read MoreMenoPal
MenoPal is creating an online digital health platform to educate and empower menopausal women with credible information and community support. MenoPal Team: Cira Cardaci Mican Meneses
Read MoreSmell-RS
Smell-RS is developing a digital diagnostic device for testing olfactory function, which is an early symptom of neurodegenerative diseases that affect 10% of the population. Smell-RS Team: Andreas Keller, CEO
Read MoreMyophonX
MyophonX is an individually tailored wearable device that applies machine learning to silent articulation to restore speech in patients with limited phonation capacity. MyophonX Team: Anais Rameau, CEO Tal Herman, Co-founder
Read MoreCardea Sciences
Heart monitor for risk evaluation of adverse events and worsening symptoms in atrial fibrillation patients based on pulse-deficit measurement. Team: Dr. Ya-El Mandel-Portnoy – Founder & CEO Dr. Gregor Schwartz – Head of R&D
Read MoreZLife Technologies
We have developed and patented a novel preservation solution to be used as a clinical treatment for ischemia-reperfusion injury in organ transplantation, particularly intestinal transplantation. Team: Ming Zhang, MD, PhD. – President, CEO Xiang Li Andrew Hitchings
Read MoreMirna Analytics
Mirna Analytics is developing a non-invasive platform tool for prognostic and diagnostic monitoring. Our current focus is on pulmonary hypertension. Team: Gabriele Grunig, DVM, PhD – Co-founder, President Serhiy Pylawka, RN, MS – Co-founder, Science Officer
Read More